- Previous Close
1.9500 - Open
1.9280 - Bid 1.9100 x --
- Ask 1.9360 x --
- Day's Range
1.9040 - 1.9520 - 52 Week Range
1.9040 - 3.0000 - Volume
151,504 - Avg. Volume
318,935 - Market Cap (intraday)
532.38M - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
12.08 - EPS (TTM)
0.1600 - Earnings Date Feb 25, 2025 - Mar 3, 2025
- Forward Dividend & Yield 0.02 (0.96%)
- Ex-Dividend Date Sep 12, 2024
- 1y Target Est
4.55
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
www.uniphar.ie3,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UPR.IR
View MorePerformance Overview: UPR.IR
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UPR.IR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UPR.IR
View MoreValuation Measures
Market Cap
527.47M
Enterprise Value
849.70M
Trailing P/E
11.71
Forward P/E
8.78
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.20
Price/Book (mrq)
1.51
Enterprise Value/Revenue
0.32
Enterprise Value/EBITDA
7.40
Financial Highlights
Profitability and Income Statement
Profit Margin
1.69%
Return on Assets (ttm)
3.76%
Return on Equity (ttm)
13.91%
Revenue (ttm)
2.68B
Net Income Avi to Common (ttm)
45.17M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
96M
Total Debt/Equity (mrq)
119.43%
Levered Free Cash Flow (ttm)
111.39M